• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克拉霉素单独或与其他药物联合用于治疗小鼠弓形虫病的活性。

Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.

作者信息

Araujo F G, Prokocimer P, Lin T, Remington J S

机构信息

Research Institute, Palo Alto Medical Foundation, California 94301.

出版信息

Antimicrob Agents Chemother. 1992 Nov;36(11):2454-7. doi: 10.1128/AAC.36.11.2454.

DOI:10.1128/AAC.36.11.2454
PMID:1489188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC284352/
Abstract

The activity of the macrolide antibiotic clarithromycin was examined alone or in combination with other drugs for the treatment of acute or chronic infections with Toxoplasma gondii in mice. A dose of 300 mg of clarithromycin per kg per day administered alone for 10 days, beginning 24 hours after infection, protected 10 to 30% of mice infected with lethal inocula of tachyzoites or tissue cysts of different strains of T. gondii, including some strains isolated from patients with both AIDS and toxoplasmosis. Although clarithromycin was protective, a wide variation in its activity against different strains was observed. Survival of infected mice was increased significantly by treatment with clarithromycin in combination with pyrimethamine or with sulfadiazine. Treatment of chronically infected mice with clarithromycin at 300 mg/kg/day administered alone for 8 weeks resulted in significant reduction in the numbers of T. gondii cysts in their brains. The combination of clarithromycin and minocycline resulted in an activity against T. gondii cysts that was significantly greater than the activity of clarithromycin or minocycline administered alone. These results indicate a role for clarithromycin in the treatment of human toxoplasmosis, particularly when this antibiotic is used in combination with other drugs with activity against T. gondii.

摘要

研究了大环内酯类抗生素克拉霉素单独使用或与其他药物联合使用对小鼠急性或慢性弓形虫感染的治疗效果。感染后24小时开始,每天每千克给予300毫克克拉霉素,单独给药10天,可保护10%至30%感染不同株弓形虫速殖子或组织包囊致死接种物的小鼠,其中包括一些从艾滋病合并弓形虫病患者中分离出的菌株。虽然克拉霉素具有保护作用,但观察到其对不同菌株的活性存在很大差异。克拉霉素与乙胺嘧啶或磺胺嘧啶联合治疗可显著提高感染小鼠的存活率。对慢性感染小鼠,每天每千克给予300毫克克拉霉素单独给药8周,可使小鼠脑中弓形虫包囊数量显著减少。克拉霉素与米诺环素联合使用对弓形虫包囊的活性显著高于单独使用克拉霉素或米诺环素。这些结果表明克拉霉素在治疗人类弓形虫病中具有一定作用,特别是当这种抗生素与其他对弓形虫有活性的药物联合使用时。

相似文献

1
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.克拉霉素单独或与其他药物联合用于治疗小鼠弓形虫病的活性。
Antimicrob Agents Chemother. 1992 Nov;36(11):2454-7. doi: 10.1128/AAC.36.11.2454.
2
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.羟萘醌阿托伐醌单独或与乙胺嘧啶、磺胺嘧啶、克拉霉素或米诺环素联合使用对刚地弓形虫的体外和体内活性。
Antimicrob Agents Chemother. 1993 Nov;37(11):2371-8. doi: 10.1128/AAC.37.11.2371.
3
Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.基于克拉霉素与米诺环素或乙胺嘧啶联合疗法对实验性弓形虫感染的治疗
J Acquir Immune Defic Syndr (1988). 1994 Nov;7(11):1141-8.
4
Rifabutin is active in murine models of toxoplasmosis.利福布汀在弓形虫病的小鼠模型中具有活性。
Antimicrob Agents Chemother. 1994 Mar;38(3):570-5. doi: 10.1128/AAC.38.3.570.
5
The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine.阿托伐醌(566C80)在与乙胺嘧啶或磺胺嘧啶联合使用时,其在鼠弓形虫病中的活性显著增强。
J Infect Dis. 1993 Feb;167(2):494-7. doi: 10.1093/infdis/167.2.494.
6
Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.磺胺嘧啶和乙胺嘧啶对巴西先天性疾病人类病例分离菌株所致实验性弓形虫病的治疗效果
Exp Parasitol. 2019 Jul;202:7-14. doi: 10.1016/j.exppara.2019.05.001. Epub 2019 May 8.
7
Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.刚地弓形虫:氟康唑联合磺胺嘧啶和乙胺嘧啶对急性弓形虫病小鼠模型的影响。
Exp Parasitol. 2013 Mar;133(3):294-9. doi: 10.1016/j.exppara.2012.12.011. Epub 2012 Dec 25.
8
Activity of minocycline against Toxoplasma gondii infection in mice.米诺环素对小鼠弓形虫感染的活性。
J Antimicrob Chemother. 1991 May;27(5):639-45. doi: 10.1093/jac/27.5.639.
9
In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.罗红霉素与乙胺嘧啶或磺胺嘧啶联合应用对刚地弓形虫的体外和体内活性
J Antimicrob Chemother. 1995 Jun;35(6):821-32. doi: 10.1093/jac/35.6.823.
10
Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii.重组杀菌/通透性增强蛋白(rBPI21)与磺胺嘧啶联合使用对刚地弓形虫具有活性。
Antimicrob Agents Chemother. 1999 Apr;43(4):758-62. doi: 10.1128/AAC.43.4.758.

引用本文的文献

1
Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation.接受螺旋霉素-壳聚糖纳米颗粒制剂后,实验性弓形虫病的组织病理学有显著改善。
J Parasit Dis. 2022 Mar;46(1):166-177. doi: 10.1007/s12639-021-01431-9. Epub 2021 Aug 10.
2
Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review.过去三十年(1987年至2017年)抗弓形虫药物及化合物对组织包囊的作用:一项系统评价
Parasitol Res. 2018 Oct;117(10):3045-3057. doi: 10.1007/s00436-018-6027-z. Epub 2018 Aug 8.
3
Assessment of spiramycin-loaded chitosan nanoparticles treatment on acute and chronic toxoplasmosis in mice.评估载有螺旋霉素的壳聚糖纳米颗粒对小鼠急性和慢性弓形虫病的治疗效果。
J Parasit Dis. 2018 Mar;42(1):102-113. doi: 10.1007/s12639-017-0973-8. Epub 2017 Dec 15.
4
Lectins from (ScLL) and (ArtinM) Are Able to Induce Beneficial Immunomodulatory Effects in a Murine Model for Treatment of Infection.来自[物种名称1](ScLL)和[物种名称2](ArtinM)的凝集素能够在小鼠治疗[感染类型]感染的模型中诱导有益的免疫调节作用。
Front Cell Infect Microbiol. 2016 Nov 25;6:164. doi: 10.3389/fcimb.2016.00164. eCollection 2016.
5
The effect of chitosan nanospheres on the immunogenicity of Toxoplasma lysate vaccine in mice.壳聚糖纳米球对小鼠弓形虫裂解物疫苗免疫原性的影响。
J Parasit Dis. 2016 Sep;40(3):611-26. doi: 10.1007/s12639-014-0546-z. Epub 2014 Sep 5.
6
A comparative study between excretory/secretory and autoclaved vaccines against RH strain of Toxoplasma gondii in murine models.在鼠模型中针对刚地弓形虫RH株的排泄/分泌疫苗与高压灭菌疫苗的对比研究。
J Parasit Dis. 2015 Sep;39(3):526-35. doi: 10.1007/s12639-013-0390-6. Epub 2013 Nov 20.
7
Antileishmanial Activity of Liposomal Clarithromycin against Leishmania Major Promastigotes.脂质体克拉霉素对利什曼原虫前鞭毛体的抗利什曼活性。
Iran J Basic Med Sci. 2012 Nov;15(6):1210-4.
8
High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period.5 年期间高剂量甘氨酸治疗难治性强迫症和躯体变形障碍。
Neural Plast. 2009;2009:768398. doi: 10.1155/2009/768398. Epub 2010 Feb 18.
9
Why prevent, diagnose and treat congenital toxoplasmosis?为什么要预防、诊断和治疗先天性弓形虫病?
Mem Inst Oswaldo Cruz. 2009 Mar;104(2):320-44. doi: 10.1590/s0074-02762009000200029.
10
Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis.阿托伐醌纳米混悬液在一种新的弓形虫病再激活小鼠模型中显示出优异的治疗效果。
Antimicrob Agents Chemother. 2001 Jun;45(6):1771-9. doi: 10.1128/AAC.45.6.1771-1779.2001.

本文引用的文献

1
[In vitro measurement of the inhibitory effect of macrolides, lincosamides and synergestines on the growth of Toxoplasma gondii].[大环内酯类、林可酰胺类及协同因子对刚地弓形虫生长抑制作用的体外测定]
Pathol Biol (Paris). 1988 Dec;36(10):1204-10.
2
Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice.新型大环内酯类药物A-56268(TE-031)对小鼠体内弓形虫的活性
J Antimicrob Chemother. 1988 Sep;22(3):359-61. doi: 10.1093/jac/22.3.359.
3
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii.阿奇霉素,一种对弓形虫具有强效活性的大环内酯类抗生素。
Antimicrob Agents Chemother. 1988 May;32(5):755-7. doi: 10.1128/AAC.32.5.755.
4
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii.四种大环内酯类药物(罗红霉素、螺旋霉素、阿奇霉素[CP-62,993]和A-56268)对刚地弓形虫的体外作用。
Antimicrob Agents Chemother. 1988 Apr;32(4):524-9. doi: 10.1128/AAC.32.4.524.
5
Activity in vitro against Toxoplasma gondii of azithromycin and clarithromycin alone and with pyrimethamine.阿奇霉素和克拉霉素单独及与乙胺嘧啶联合应用对体外弓形虫的活性。
J Antimicrob Chemother. 1990 Apr;25(4):708-11. doi: 10.1093/jac/25.4.708.
6
Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii.羟基萘醌566C80对刚地弓形虫速殖子和组织包囊具有显著的体外和体内活性。
Antimicrob Agents Chemother. 1991 Feb;35(2):293-9. doi: 10.1128/AAC.35.2.293.
7
Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS.乙胺嘧啶-克拉霉素联合用药治疗艾滋病患者的急性弓形虫脑炎
Antimicrob Agents Chemother. 1991 Oct;35(10):2049-52. doi: 10.1128/AAC.35.10.2049.
8
Synergistic activity of azithromycin and gamma interferon in murine toxoplasmosis.阿奇霉素与γ干扰素在小鼠弓形虫病中的协同活性
Antimicrob Agents Chemother. 1991 Aug;35(8):1672-3. doi: 10.1128/AAC.35.8.1672.
9
In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.大环内酯类抗生素阿奇霉素、罗红霉素和螺旋霉素对刚地弓形虫的体内活性
Eur J Clin Microbiol Infect Dis. 1991 Jun;10(6):519-24. doi: 10.1007/BF01963942.
10
Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii.药物对刚地弓形虫包囊形式影响的评估。
J Infect Dis. 1991 Jul;164(1):170-1. doi: 10.1093/infdis/164.1.170.